F-group (family)

3016.1.1.2 Aminotran_3

Ligands and drugs

1,053
Member domains
285
with ligand contacts (≤ 4 Å)
27.1% of members
265
with DrugDomain annotations
25.2% of members
144
with a DrugBank compound
13.7% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 3016.1.1.2 belongs to X-group 3016 C-terminal domain in some PLP-dependent transferases, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB04467PDAN-(5'-phosphopyridoxyl)-L-alanine12
DB00114PLPPyridoxal phosphate7
DB02274KAP7-Keto-8-Aminopelargonic Acid6
DB00139SINSuccinic acid4
DB02635ILPN-[O-Phosphono-Pyridoxyl]-Isoleucine4
DB01917PUTPutrescine3
DB03345BMEMercaptoethanol3
DB00119—Pyruvic acid2
DB00160—Alanine2
DB01813PPEPyridoxyl-Glutamic Acid-5'-Monophosphate2
DB02068DAVDelta-Amino Valeric Acid2
DB02379BGCBeta-D-Glucose2
DB02725ACZ2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid2
DB03582SUON~2~-Succinylornithine2
DB04235VIG4-Amino Hexanoic Acid2
DB08845AKGOxogluric acid2
DB00129—Ornithine1
DB00142—Glutamic acid1
DB00145—Glycine1
DB00513ACAAminocaproic acid1

Most frequently bound compounds

PDB ligandNameDomains in contact
PLPPYRIDOXAL-5'-PHOSPHATE20
PDA2-[(3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL)-AMINO]-PROPIONIC ACID12
RW2(1S)-4-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]cyclopent-3-ene-1,3-dicarboxylic acid11
CLCHLORIDE ION8
I1T(1S,3R,4S)-3-formyl-4-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]cyclopentane-1-carboxylic acid8
J4J2-[(2-nitrophenyl)sulfanyl]acetohydrazide8
KAP7-KETO-8-AMINOPELARGONIC ACID8
7VO(2S,3S)-3-methyl-2-[[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylamino]pentanoic acid4
CDmetalCADMIUM ION4
ICCazepan-2-one4
ILPN-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE4
BMEBETA-MERCAPTOETHANOL3
IF1(1S,3S,4S)-3-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]-4-(1,1,3,3,3-pentafluoroprop-1-en-2-yl)cyclopentane-1-carboxylic acid3
MGmetalMAGNESIUM ION3
PMP4'-DEOXY-4'-AMINOPYRIDOXAL-5'-PHOSPHATE3
RMT(3R,4E)-4-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)imino]cyclopent-1-ene-1,3-dicarboxylic acid3
Y37(1R,4R)-4-fluoro-3-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]cyclopent-2-ene-1-carboxylic acid3
2B1(4-{[(E)-1,3-benzothiazol-2-yldiazenyl]methyl}-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate2
3G87-(diethylamino)-3-(thiophen-2-ylcarbonyl)-2H-chromen-2-one2
3GSdimethyl (2R)-5-(3-fluorophenyl)-1H-pyrrolo[1,2-c][1,3]thiazole-6,7-dicarboxylate 2-oxide2